trellicell easily fits for various applications and uses across a wide range of industries such as medical, pharmaceutical, food, artificial tissue regeneration etc for cell culture and tissue engineering.
trellicell is being developed by Molekulare Biotechnolgie e.U., Austria based biotechnology company working towards revolutionizing the use of biodegradable polymers for wide variety of cell growth applications. trellicell offers high-performance biodegradable polymers suited to develop many innovative and life changing products for a broad range of industries.
Developed by a team of world class researchers and backed by medtech innovators and investors with extensive industry experience in bringing new products to life, trellicell is set to disrupt the artificial cell growth Industry in coming years.
Solve real life world problems related to health and food by innovating superior polymers.
To become industry leader in developing biodegradable scaffolds promoting artificial cell growth.
trellicell technology is utilizing a scaffold composed of specific polymer compounds that deliver the physical properties from polymer, while still being 100% absorbable.
trellicell also helps in controlled release of substances such as drugs or antibiotics that help in wound repair and healing.
In the early stages of bone healing trellicell Net preserves fixation. Over time, the implant gradually decomposes, and the stresses are steadily transferred to the healing tissue, Providing continuous support for new tissue growth.
Properties of trellicell-Net for bone implants
trellicell drug delivery capsules help in controlled release of drugs in the body. These capsules are programmed to release drugs at a precise, predictable time, so that multiple doses of a drug or vaccine can be delivered over an extended time period with just one injection or oral capsule.
Properties of trellicell-Net for drug delivery
Resorbable implant market overview
Market growth drivers
Advantage of Cultured meat are
Artificial meat market overview
Market growth drivers
Organoids help in screening the efficacy of drugs against various human diseases. The unique capacity of trellicell Organoids to recapitulate characteristics of the personalized organ they originate from opens up new possibilities for research, drug discovery and development. Testing drugs on 3D bioprinted organs has the potential to optimize and accelerate the drug development process.
Some of the greatest impacts of organoid development are following:
Properties of trellicell scaffold for organ growth
Better use of resources
Higher success rate of clinical trials
No more animal testing
Speedy Research and Treatment
Industry growth drivers
Institute of Molecular Biotechnology,
Graz University of Technology &
Austrian Centre of Industrial Biotechnology GmbH (ACIB)
1968 – 1973: Diploma study (degree “Dipl.Ing.”) on Technical Chemistry with specialization on Biochemistry/Biotechnology.
1976 – 1980: Doctoral thesis “Transfer of Plasmid-DNA into the bacterium Alcaligenes eutrophus H16″
1974 – 1985: Assistant at the Institute of Biotechnology of TU Graz (Graz University of 1979:
1979: 6 months period in industry (Vogelbusch GmbH, Vienna), Yeast fermentation at 200 m³ scale (continuous)
1983 – 1985: two years period in industry, establishing molecular genetics group, Sandoz (now Novartis) GmbH , Kundl
1985 – 2003: assistant/associate professor at the Institute of Biotechnology, University of Technology, Graz.
1988: Habilitation: “Biotechnology with Special Emphasis on Gene Technology”
1995: Fulbright Senior Research Fellow, Sabbatical at the Center for Molecular Genetics, UCSD, La Jolla, CA
Since 2002: Foundation and leading (CEO) of SME “Molekulare Biotechnologie GmbH”
2003 – Sept 2015: Full Professor (chair) of Molecular Biotechnology at Graz University of Technology
Since Oct. 2015: officially retired, still active in research and teaching, part time employment at TU Graz
Since March 2017: Part time employment at Austrian Centre for Industrial Biotechnology – Key Researcher, PI for projects on Cell and protein engineering
Research interests are focussed on molecular biotechnology and include heterologous gene expression (protein and metabolite production) in industrial microorganisms (bacteria, fungi) , molecular enzymology, enzyme engineering and microbial cell engineering for cell factory construction, biological carbon dioxide fixation for bio-production of chemicals, fuels and biopolymers. Projects funded by national (FWF, FFG, CDG) and international (EU) agencies as well as industry.
Various industry co-operation projects, mostly in the frame of the Austrian Center for Industrial Biotechnology (ACIB) and of the Christian Doppler Laboratories: Topics include recruiting and developing industrial enzymes, heterologous expression of proteins in bacteria and fungi, enzyme engineering by rational and random approaches.
2002-2009: Key Researcher at the Competence Centre “Applied Biocatalysis”
2010-2014: Head of Area “Protein Design and Engineering” and Key researcher of the
Austrian Centre of Industrial Biotechnology (ACIB).
2015: Head of the Area “Bioprospecting and Synthetic Biology” of the Austrian Centre of Industrial Biotechnology (ACIB).
2015: retired from position as university professor, still active in different research projects, mainly in the frame of ACIB (industry cooperation)
2002:-2008: Vice president & President of the Austrian Society for Biotechnology
Member of External Scientific Advisory Boards
Editor of “Journal of Biotechnology”
Board of editors of “Applied Microbiology and Biotechnology”
Editor of FEMS Microbiology Reviews (2011-2013)
2000: DSM Research award
2006: Dr. Wolfgang Houska Award , 1st Price (Team member)
2007: DSM Innovation Award
2009: Dr. Wolfgang Houska Award, recognition price (Team member)
> 30 patent applications
> 140 publications in scientific journals
With an academic background in Economics and Engineering I started my career in Business Development with international large corporations.
My time in the Bay Area triggered my passion for innovation and now I am a full time entrepreneur and investor, always looking to push another exciting new business opportunity.
Anshu graduated top of her class from California State University, East Bay, USA with an MBA degree specializing in Finance.
She specializes in consulting and providing strategic support to start-ups, growth companies and investors to ideate, evaluate, capitalize and scale new products and services.
Still studying at the Technical University of Vienna, Florian was already working part-time as web developer implementing proprietary CM-Systems.
For his master thesis he had the opportunity to implement the mobile app for one of the 4 largest banks in Austria. Taking it, he switched to Android development. By today he has built an impressive track record reaching millions of people with apps from the fields of finance, arts, government, sports and IT.